Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXHL1600050	托格列净片	tofogliflozin	Tablet	Chemical Drugs(3.1)	New Drug Application	2016-06-02	南京华威医药科技开发有限公司	Nanjing Huawei Medicine Technology Development Co Ltd	Certificate Issued	2017-05-11	view
JYHB2400450	艾托格列净片	ertugliflozin	Tablet	Chemical Drugs(5.1)	Supplementary Application	2024-08-15		Pfizer Manufacturing Deutschland GmbH;Merck Sharp & Dohme BV			view
JYHB2200192	艾托格列净片	ertugliflozin	Tablet	Chemical Drugs	Supplementary Application	2022-04-11		Pfizer Manufacturing Deutschland GmbH;Merck Sharp & Dohme BV			view
CYHS2404557	艾托格列净片	ertugliflozin	Tablet	Chemical Drugs(4)	Generic Drug	2024-12-26		Shandong Langnuo Pharmaceutical Co Ltd			view
JYHB2101055	艾托格列净片	ertugliflozin	Tablet	Chemical Drugs(5.1)	Supplementary Application	2021-04-23		Pfizer Manufacturing Deutschland GmbH;Merck Sharp & Dohme BV			view
JYHB2002203	艾托格列净片	ertugliflozin	Tablet	Chemical Drugs(5.1)	Supplementary Application	2020-11-02	默沙东研发（中国）有限公司	MSD R&D (China) Co Ltd;Merck Sharp & Dohme Ltd;Pfizer Manufacturing Deutschland GmbH	Filed	2020-11-20	view
JYHZ2400270	艾托格列净片	ertugliflozin	Tablet	Chemical Drugs(5.1)	License Renew	2024-10-11		Pfizer Manufacturing Deutschland GmbH;MSD R&D (China) Co Ltd;Merck Sharp & Dohme BV			view